<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="n95/PMC3523505/results/search/disease/results.xml">
  <result pre="(57%). The most commonly reported adverse effects were nausea (54%)," exact="gastritis" post="(51%), and headache (38%). Conclusion: Chemoprophylaxis with oseltamivir is"/>
  <result pre="rate in the high-risk group was 5.7/1000 person weeks) of" exact="influenza" post="A (H1N1) infection during the 2009 pandemic.[ 2] None"/>
  <result pre="equal sex distribution. None of them had received any prior" exact="influenza" post="vaccine. Reasons for exclusion of 50 HCP from the"/>
  <result pre="the symptoms develop, and the effectiveness of oseltamivir in preventing" exact="influenza" post="in household contacts has been proved.[ 9] Systematic review"/>
  <result pre="the role of neuraminidase inhibitors have been conducted during seasonal" exact="influenza" post="outbreaks. In pandemics, large population of healthy adults are"/>
  <result pre="suboptimal means of interrupting viral spread in a pandemic. Novel" exact="influenza" post="viruses are very efficient agents causing rapid spread and"/>
  <result pre="Common ADRs in both the groups were gastritis, nausea, vomiting," exact="diarrhea" post="weakness, sedation, loneliness, sadness, headache, and abdominal pain. Results"/>
  <result pre="incidence of 57% of ADRs among HCP. Though nausea and" exact="gastritis" post="were the most common similar to the previous study,"/>
  <result pre="development of oseltamivir-resistant H1N1 virus[ 18] and is discouraged. During" exact="influenza" post="pandemics, emphasis should be laid on infection control procedures,"/>
  <result pre="Oh WS Moon CS Park KH et al. 2009 H1N1" exact="influenza" post="infection in Korean healthcare personnel Eur J Clin Microbiol"/>
  <result pre="S Smits PH et al. Low attack rate of novel" exact="influenza" post="A (H1N1) virus infection among healthcare workers: A prospective"/>
  <result pre="World Health Organization (Internet) CDC protocol of realtime RT-PCR for" exact="influenza" post="A (H1N1) Last cited on 2009 Nov 21 Available"/>
  <result pre="Lanno R Hughes C Small I et al. Management of" exact="influenza" post="in households: A prospective, randomized comparison of oseltamivir treatment"/>
  <result pre="P Del Mar C Neuraminidase inhibitors for preventing and treating" exact="influenza" post="in healthy adults: Systematic review and meta-analysis BMJ 2009"/>
  <result pre="Use of the selective oral neuraminidase inhibitor oseltamivir to prevent" exact="influenza" post="N Engl J Med 1999 341 1336 43 10536125"/>
  <result pre="Thakrar B et al. Assessment of neuropsychiatric adverse events in" exact="influenza" post="patients treated with oseltamivir: A comprehensive review Drug Saf"/>
  <result pre="2008 31 1097 114 19026027 15 Maltezou HC Novel (pandemic)" exact="influenza" post="A H1N1 in healthcare facilities: Implications for prevention and"/>
  <result pre="KK et al. Prevention of nosocomial transmission of swine-origin pandemic" exact="influenza" post="virus A/H1N1 by infection control bundle J Hosp Infect"/>
  <result pre="18 Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel" exact="influenza" post="A (H1N1) virus infection in two immunosuppressed patients -seattle,"/>
  <result pre="6 19696719 19 Gupta D Mootha VK Neuraminidase inhibitors for" exact="influenza" post="in healthy adults: What we donâ€™t know Natl Med"/>
 </snippets>
</snippetsTree>
